Sonic hedgehog promotes endothelial differentiation of bone marrow mesenchymal stem cells via VEGF-D

被引:24
|
作者
Shi, Sheng [1 ,2 ,3 ]
Sun, Jiacheng [1 ,2 ]
Meng, Qingyou [1 ,2 ]
Yu, Yunsheng [1 ,2 ]
Huang, Haoyue [1 ,2 ]
Ma, Teng [1 ,2 ]
Yang, Ziying [1 ,2 ]
Liu, Xuan [1 ,2 ]
Yang, Junjie [1 ,2 ]
Shen, Zhenya [1 ,2 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, 899 Pinghai Rd, Suzhou 215006, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Inst Cardiovasc Sci, Suzhou 215006, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Cardiovasc Surg, Shanghai 201620, Peoples R China
基金
中国国家自然科学基金;
关键词
Sonic hedgehog (Shh); bone marrow-derived mesenchymal stem cells (BMSCs); endothelial differentiation; angiogenesis; vascular endothelial growth factor D (VEGF-D); GENE-THERAPY; ANGIOGENESIS; EXPRESSION; ISCHEMIA; SURVIVAL; HYPOXIA;
D O I
10.21037/jtd.2018.09.50
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Bone marrow-derived mesenchymal stem cells (BMSCs) have been proved to be capable of differentiating into endothelial cells (ECs), however, the differentiation efficiency is rather low. Sonic hedgehog (Shh), an important factor in vascular development and postnatal angiogenesis, exerted promotional effect on new vessel formation in the ischemic animal models. Therefore, the current study aims to investigate whether Shh could induce the endothelial differentiation of BMSCs both in vitro and in vivo, as well as the mechanism of differentiation induction. Methods: The current study over-expressed Shh in BMSCs by lentivirus transduction. Reverse-transcription quantitative polymerase chain reaction (RT-qPCR) analysis was performed to determine the angiogenic factors in both control BMSCs and Shh over-expressed BMSCs. Immunocytochemistry was also conducted to examine the EC markers. Angiogenesis was determined by in vitro tube-forming assay on Matrigel and in vivo Matrigel plug in severe combined immunodeficient (SCID) mice. Last, mRNA sequencing analysis was used to elaborate the underlying mechanisms. Loss of function study was performed by vascular endothelial growth factor D (VEGF-D) siRNA. Results: Shh expression was increased by about 3,000-fold and 5,000-fold at 3 days-transfection and 7 days-transfection, respectively. Patched 1 (Ptch1), the receptor for Shh, had a two-fold increase after transduction. The angiogenic factors such as hepatocyte growth factor (HGF), angiopoietin-1 (Ang-1), insulin-like growth factor 1 (IGF1) and vascular endothelial growth factor A (VEGF-A) had at least a 1.5-fold increase after transduction. Expression of EC-lineage markers, CD31 and VE-cadherin, on Shh-overexpressed BMSCs were increasingly detected by immunocytostaining. Angiogenesis of BMSCs could be efficiently induced by Shh overexpression in the in vitro tube-formation assay and in vivo Matrigel plug. Additionally, mRNA sequencing analysis revealed that Shh activation upregulated the expression of several pro-angiogenic factors, like Angptl4, Egfl6, VEGF-D. Loss of function study by VEGF-D siRNA confirmed that Shh enhanced the angiogenic ability of BMSCs via VEGF-D. Conclusions: This study demonstrated that Shh could promote endothelial differentiation of BMSCs via VEGF-D.
引用
收藏
页码:5476 / +
页数:14
相关论文
共 50 条
  • [31] VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
    Steven A. Stacker
    Carol Caesar
    Megan E. Baldwin
    Gillian E. Thornton
    Richard A. Williams
    Remko Prevo
    David G. Jackson
    Shin-ichi Nishikawa
    Hajime Kubo
    Marc G. Achen
    Nature Medicine, 2001, 7 : 186 - 191
  • [32] VEGF secreted by mesenchymal stem cells mediates the differentiation of endothelial progenitor cells into endothelial cells via paracrine mechanisms
    Ge, Quanhu
    Zhang, Hongwei
    Hou, Jixue
    Wan, Longfei
    Cheng, Wenzhe
    Wang, Xiaoyi
    Dong, Dan
    Chen, Congzhe
    Xia, Jie
    Guo, Jun
    Chen, Xueling
    Wu, Xiangwei
    MOLECULAR MEDICINE REPORTS, 2018, 17 (01) : 1667 - 1675
  • [33] PURMORPHAMINE INHIBITS BONE MARROW MESENCHYMAL STEM CELLS ADIPOGENIC DIFFERENTIATION AND PROMOTED OSTEOGENIC DIFFERENTIATION VIA HEDGEHOG/WNT/β-CATENIN SIGNAL PATHWAY
    Zhang, L. W.
    Lei, X. H.
    Fu, X. J.
    Zhu, M.
    Chen, J. Q.
    Hong, D.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S528 - S528
  • [34] ESTROGEN PROMOTES THE CHEMOTACTIC MIGRATION AND DIFFERENTIATION OF BONE MARROW MESENCHYMAL STEM CELLS IN ENDOMETRIOSIS.
    Zhang, Wenbi
    Li, Lu
    Sun, Xiaoxi
    FERTILITY AND STERILITY, 2019, 112 (03) : E329 - E329
  • [35] Icariin promotes directed chondrogenic differentiation of bone marrow mesenchymal stem cells but not hypertrophy in vitro
    Wang, Zhi Cong
    Sun, Hui Jun
    Li, Kai Hua
    Fu, Chao
    Liu, Mo Zhen
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 8 (05) : 1528 - 1534
  • [36] miRNA-101 promotes chondrogenic differentiation in rat bone marrow mesenchymal stem cells
    Gao, Feng
    Peng, Chuangang
    Zheng, Changjun
    Zhang, Shanyong
    Wu, Minfei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (01) : 175 - 180
  • [37] Laminin matrix promotes hepatogenic terminal differentiation of human bone marrow mesenchymal stem cells
    Khalaj, Zahra
    Lotfi, Abbas Sahebghadam
    Kabir-Salmani, Maryam
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2016, 19 (01) : 34 - 42
  • [38] PPARγ inhibition promotes osteogenic differentiation of bone marrow mesenchymal stem cells and fracture healing
    Yang, Guohui
    Liu, Kexi
    Ma, Shengli
    Qi, Peiyi
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2024, 125 (06)
  • [39] Low level light promotes the proliferation and differentiation of bone marrow derived mesenchymal stem cells
    Ahn, Jin-Chul
    Rhee, Yun-Hee
    Choi, Sun-Hyang
    Kim, Dae Yu
    Chung, Phil-Sang
    MECHANISMS FOR LOW-LIGHT THERAPY X, 2015, 9309
  • [40] Differentiation of Rabbit Bone Marrow Mesenchymal Stem Cells to Myogenic Cells and Expression of VEGF After Gene Transfection
    盛小刚
    宋卉
    冯建章
    陈秋雄
    South China Journal of Cardiology, 2005, (02) : 63 - 66